Treatment of multiple sclerosis with an anti–interleukin‐2 receptor monoclonal antibody
Year: 2004
Type: article
Study design: Clinical Trial
Source: Annals of Neurology
DOI: 10.1002/ana.20287
Institutions: University of Utah, VA Salt Lake City Healthcare System
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2121931605
